This grant opportunity (PAR-25-327) from NIH supports translational efforts to advance gene-based therapies for ultra-rare neurological and neuromuscular disorders. It is a U01 grant, and clinical trials are optional.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.